Apple has been issued a warning letter from the U.S. Federal Trade Commission, urging it to review its content curation for Apple News so as to ensure that it is not suppressing conservative ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Federal Trade Commission is ...

The US Federal Trade Commission (FTC) on Friday issued warning letters to 42 law firms, stating that their participation in a diversity certification program may violate federal antitrust laws.

Federal Trade Commission officials and witnesses offered many critiques of noncompete agreements during a public hearing Tuesday, but little in the way of proposals that would match the scope of the ...

A federal judge found that Meta does not have a monopoly over personal social networking services. A federal judge found that Meta does not have a monopoly over personal social networking services. is ...

The Federal Trade Commission (FTC) said Tuesday that it plans to appeal a November ruling finding that Meta did not have a monopoly over personal social networking. The agency, which sued the Facebook ...

Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...

Learn how to use advanced techniques like short-circuiting, parallel execution, virtual threads, and stream gatherers to maximize Java stream performance. My recent Java Stream API tutorial introduced ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The Federal Trade Commission (FTC) has begun outlining its case against Edwards Lifesciences' proposed purchase of heart implant developer JenaValve after the antitrust agency announced it would move ...

As Novo Nordisk and Pfizer vie for control of Metsera, a new round of takeout proposals has resulted in the obesity biotech declaring Novo's offer "superior"—even though it has already inked an ...